[{"address1": "Chemin des Aulx, 12", "address2": "Plan-les-Ouates", "city": "Geneva", "zip": "1228", "country": "Switzerland", "phone": "41 22 552 38 40", "website": "https://www.obseva.com", "longBusinessSummary": "ObsEva SA, a biopharmaceutical company, focuses on the development of novel therapies to improve women's reproductive health. It develops Nolasiban, an oral oxytocin receptor agonist for improving clinical pregnancy and live birth rates in women undergoing in-vitro fertilization. ObsEva SA was founded in 2012 and is headquartered in Geneva, Switzerland.", "fullTimeEmployees": 15, "companyOfficers": [{"maxAge": 1, "name": "Dr. Ernest  Loumaye M.D., OB/GYN, Ph.D.", "age": 70, "title": "Co-Founder & Chairman", "yearBorn": 1952, "fiscalYear": 2022, "totalPay": 40000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Fabien Lefebvre de Ladonchamps", "age": 43, "title": "CEO & Director", "yearBorn": 1979, "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Delphine  Renaud", "title": "Personal Assistant to the CSO and Head of R&D", "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1672444800, "maxAge": 86400, "priceHint": 4, "previousClose": 0.0375, "open": 0.05, "dayLow": 0.03, "dayHigh": 0.05, "regularMarketPreviousClose": 0.0375, "regularMarketOpen": 0.05, "regularMarketDayLow": 0.03, "regularMarketDayHigh": 0.05, "beta": 0.725, "volume": 62246, "regularMarketVolume": 62246, "averageVolume": 20812, "averageVolume10days": 70577, "averageDailyVolume10Day": 70577, "fiftyTwoWeekLow": 1e-06, "fiftyTwoWeekHigh": 0.1, "fiftyDayAverage": 0.04692, "twoHundredDayAverage": 0.053897046, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "enterpriseValue": 1517205, "profitMargins": 0.40342, "floatShares": 102591058, "heldPercentInsiders": 0.08922, "heldPercentInstitutions": 0.00727, "bookValue": 0.027, "priceToBook": 1.2962962, "lastFiscalYearEnd": 1672444800, "nextFiscalYearEnd": 1703980800, "mostRecentQuarter": 1688083200, "netIncomeToCommon": 7922000, "enterpriseToRevenue": 0.077, "enterpriseToEbitda": 0.298, "52WeekChange": 34999.0, "SandP52WeekChange": 0.2508303, "exchange": "PNK", "quoteType": "EQUITY", "symbol": "OBSEF", "underlyingSymbol": "OBSEF", "shortName": "OBSEVA SA", "longName": "ObsEva SA", "firstTradeDateEpochUtc": 1686317400, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EST", "uuid": "5fd65602-5ead-30cf-b72f-fc8ea576574e", "messageBoardId": "finmb_245335894", "gmtOffSetMilliseconds": -18000000, "currentPrice": 0.035, "recommendationKey": "none", "totalCash": 3340000, "totalCashPerShare": 0.029, "ebitda": 5097000, "totalDebt": 756000, "quickRatio": 0.732, "currentRatio": 0.752, "totalRevenue": 19637000, "debtToEquity": 24.324, "revenuePerShare": 0.183, "returnOnAssets": 0.10052, "returnOnEquity": 15.76517, "freeCashflow": 20147376, "operatingCashflow": -2052000, "revenueGrowth": -0.999, "grossMargins": 0.45459998, "ebitdaMargins": 0.25956, "operatingMargins": -950.5714, "financialCurrency": "USD", "trailingPegRatio": null}]